DOCSLIB.ORG

Flow Reagents Single Color Antibodies CD Chart

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Flow Reagents Single Color Antibodies CD Chart CD CHART CD N° Alternative Name CD N° Alternative Name CD N° Alternative Name Beckman Coulter Clone Beckman Coulter Clone Beckman Coulter Clone T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells CD1a T6, R4, HTA1 Act p n n p n n S l CD99 MIC2 gene product, E2 p p p CD223 LAG-3 (Lymphocyte activation gene 3) Act n Act p n CD1b R1 Act p n n p n n S CD99R restricted CD99 p p CD224 GGT (γ-glutamyl transferase) p p p p p p CD1c R7, M241 Act S n n p n n S l CD100 SEMA4D (semaphorin 4D) p Low p p p n n CD225 Leu13, interferon induced transmembrane protein 1 (IFITM1). p p p p p CD1d R3 Act S n n Low n n S Intest CD101 V7, P126 Act n p n p n n p CD226 DNAM-1, PTA-1 Act n Act Act Act n p n CD1e R2 n n n n S CD102 ICAM-2 (intercellular adhesion molecule-2) p p n p Folli p CD227 MUC1, mucin 1, episialin, PUM, PEM, EMA, DF3, H23 Act p CD2 T11; Tp50; sheep red blood cell (SRBC) receptor; LFA-2 p S n p n n l CD103 HML-1 (human mucosal lymphocytes antigen 1), integrin aE chain S n n n n n n n l CD228 Melanotransferrin (MT), p97 p p CD3 T3, CD3 complex p n n n n n n n n n l CD104 integrin b4 chain; TSP-1180 n n n n n n n p p CD229 Ly9, T-lymphocyte surface antigen p p n p n n n p p CD3d CD3δ p CD105 endoglin n n n n S n n p p l CD230 Prion protein, PrPc p p p p p p p p p CD3e CD3ε p CD106 VCAM-1 (vascular cell adhesion molecule-1), INCAM-110 n n n n S n n Folli Act l CD231 TALLA-1, TM4SF2, A15, MXS1, CCG-B7 CD3g CD3γ p CD107a LAMP-1 Act Act Act Act Act Act n l CD232 VESP R, PLXNC1, plexin C1 p p p p p CD4 T4 S n p n p n n n n n l CD107b LAMP-2 Act Act Act Act Act Act n CD233 band 3, SLC4A1, AE1, Diego blood group, EPB3 n n n n n p n CD5 T1, Tp67 p S / Low n n n n n l CD108 JMH human blood group antigen, Sema L, GPI-gp80 Low Low n n p CD234 Fy-glycoprotein, Duffy blood group antigen, DARC n n n n n p n p p CD6 T12, Tp120 p S n n n n l CD109 8A3, E123, platelet activation factor Act n n n n Act n S p S l CD235a Glycophorin A, PAS-2 n n n n n p p n l CD7 gp40, Tp41 S n n S n n n p l CD110 TPO-R (thrombopoietin receptor), c-mlp n n n n n p n p n p p CD235b Glycophorin B, PAS-3 p CD8 T8, LeuT S n n S n n n n n n l CD111 PRR1, nectin1, Hve C1, PVRL1 n n S p p p S p p CD236 Glycophorin C/D p CD8b - S n n n n n n n n n l CD112 PRR2, nectin2, Hve B, PVRL2 n S p p n S p p CD236R Glycophorin C p CD9 p24, MRP-1, MIC3, Tspan-29 Act Act Low p p n p p l CD113 PRR3 , nectin 3, PVRL3 p CD238 Kell blood group antigen p CD10 CALLA, neutral endopeptidase (NEP), gp100 n n p n n n n p l CD114 G-CSFR, HG-CSFR, CSF3R n n p n p p n p p CD239 B-CAM, Lutheran glycoprotein p p p CD11a aL integrin chain; LFA-1, gp180/95 p p Low p p n n l CD115 M-CSFR, CSF-1R, c-fms n n n p n n p n CD240 Rh blood group system, Rh30CE p p CD11b aM integrin chain, Mac-1, Mo1, CR3, a-chain of C3biR S S p p p n Folli n l CD116 GM-CSF receptor a-subunit n n p n p n n p l CD241 RhAG, Rh50 n n n n n n p n n CD11c aX integrin chain, p150,95, CR4 S / Low S / Low Low p p n p n l CD117 c-kit, stem cell factor receptor (SCFR) n n n n n n n p n n l CD242 ICAM-4, LW blood group n n n n n n p p n CD11d integrin aD subunit p CD118 LIFR (leukemia inhibitory factor receptor) p CD243 MDR-1 (multidrug resistance protein I), Pgp (P-glycoprotein) n n n n n n n p p p l CDw12 p90-120 n n p p p p n p CD119 IFNγ receptor a-chain, IFNγRI p p p p p n p CD244 2B4, NAIL, p38 S n S p p l CD13 Aminopeptidase N, APN, (EC 3.4.11.2), gp150, ANPEP p n p n p n n p p p l CD120a TNF receptor type 1, TNFR p55 p p p p p n p p p l CD245 p220/240 S / Low p p p p CD14 LPS receptor n Low Low n p l CD120b TNF receptor type 2, TNFR p75 p p p p p n p p p l CD246 ALK (anaplastic lymphoma kinase) CD15 Lewis X (Le-X), 3-fucosyl-N-acetyl-lactosamine ( 3-FAL) S / Act S / Act p n p n n p S / Act n S l CD121a IL-1 receptor type I p n n n n n n n p n CD247 T-cell receptor z-chain , CD3z p p CD16 CD16a, FcγRIIIa S / Act n p p p n n p l CD121b IL-1 receptor type II n p S p n n n S CD248 TEM1, Endosialin, CD164L1 p CD16b FcγRIIIb p n n l CD122 IL-2Rb p p n p p n n n l CD249 Aminopeptidase A p CD17 LacCer, lactosylceramide p S p n p p n Tons p p CD123 IL-3Ra n S p p p p p l CD252 OX40L, CD134L, TXGP1, TNFSF4 p p p CD18 b2 integrin chain p p p p p p n p n l CD124 IL-4Ra Act Act n n p n n p n n p CD253 TRAIL, APO2L, TNFSF10 Act p p p CD19 B4 , Bgp95 n p n n n n n p Folli n n l CD125 IL-5Ra n S S n n n n n CD254 TRANCE, TNFSF11, RANKL Act CD20 B1, Bgp35 Low p n n n n n n Folli n n l CD126 IL-6Ra p p n n p n l CD255 TWEAK, APO3L, DR3-L, TNFSF12 p p p p CD21 CR2, EBV-R, C3d-receptor, gp140 S p n n n n n p Folli n Low l CD127 IL-7Ra p n n p n n p n l CD256 APRIL, TNFSF13, TALL2 p CD22 BL-CAM, Siglec2, Bgp135 n p n n n n n p n n n l CD128a IL-8Ra, CXCR1-> Reassigned CD181 see CD181 CD257 BLyS , BAFF, TALL1 , TNFSF13B p p CD23 FcεRII, Blast-2, low affinity IgE receptor, IGEBF, gp50-45 p Act p n p p n Folli n p l CD128b IL-8Rb, CXCR2 -> Reassigned CD182 see CD182 CD258 LIGHT, TNFSF14 S CD24 BA-1, HSA (Heat stable antigen homologue) n p p n n n n n n n p l CD129 IL-9Ra p p CD261 TRAIL-R1, DR4, TNFRSF10A CD25 IL-2Ra, Tac antigen S / Act Act n p p n n n n n n l CD130 gp130 Low Act Low Low p n p n p CD262 TRAIL-R2, DR5, TNFRSF10B CD26 DPPIV ectoenzyme, ADA-binding protein, Tp103 p p n p p n n n n n p l CD131 common b-chain n n p n p p CD263 TRAIL-R3, DcR1, TNFRSF10C p p p p p CD27 T14, S152, Tp55, TNFRSF7 p Act n p n n n n n n n l CD132 common γ-chain, IL-2Rγ p p p p p n CD264 TRAIL-R4, DcR2, TNFRSF10D, TRUNDD p p p p p n CD28 Tp44 S n n n n n n n n n n l CD133 PROML1 (prominin-like 1) n n n n n n n p n p p CD265 TRANCE-R, RANK, TNFRSF11A, EOF, FEO, OFE, ODFR, PDB2 p p p p p n n p CD29 platelet GPIIa, VLA-bchain, Integrin b1 chain p p Low p p p p p p p l CD134 OX40, TNFRSF4 Act n n l CD266 TWEAK-R, TNFRSF12A, FN14 p CD30 Ki-1 antigen, Ber-H2 antigen, TNFRSF8 Act Act n Act p n n p p n l CD135 FLT3, STK-1 n n n n n n n p n l CD267 TACI, TNFRSF13B p CD31 PECAM-1, platelet GPIIa’, endocam S S p p p p n p l CD136 RON, MSP-R (macrophage stimulating protein receptor) p p l CD268 BAFFR, BR3 p p p p p n CD32 FCγRII, FCGR2A, gp40 S / Low p p n p p n n l CD137 4-1BB, ILA (induced by lymphocyte activation), TNFRSF9 Act Act n n p Folli p CD269 BCMA, BCM, TNFRSF17 CD32b FCGR2B, IGFR2 S p p n p p n p CD138 Syndecan-1, heparan sulfate proteoglycan n p n n n n n p p p l CD270 TNFRSF14, TR2, ATAR, HVEA, HVEM, LIGHTR p p S CD32c FCGR2C, IGFR2 p p p CD139 - n p p n p Low n Folli CD271 NGFR (p75), LNGFR, NTR, TNFRSF16 Folli CD33 My9, gp67, p67, Siglec3 S / Act n Low n p n n p p n n l CD140a PDGF Ra (platelet-derived growth factor receptor a) n n n n n p n p CD272 BTLA (B and T lymphocyte attenuator) p p n p S CD34 gp105-120, My10 n n n n n n n p n p l CD140b PDGF Rb (platelet-derived growth factor receptor b) n n n n n n n p CD273 PD-L2, B7-DC, PDCD1LG2 Act Act CD35 CR1, C3b/C4b receptor, Immune Adherence Receptor S p p S S n p Folli l CD141 TM (thrombomodulin), fetomodulin, BDCA-3 n n p n p p n p p l CD274 B7-H1, PD-L1, PDCD1LG1 p p p p p p l CD36 platelet GPIV, GPIIIb, OKM5-antigen, PASIV n n n n p p p p p p n l CD142 Tissue factor, thromboplastin, coagulation factor III n n n n p n p p CD275 B7-H2, B7RP-1, ICOS-L, GL50 p p p n p p CD37 gp52-40, Tspan-26 Low p Low n Low n n l CD143 ACE (angiotensin-converting enzyme), peptidyl dipeptidase A S n n n Act n n p p CD276 B7-H3 Act Act Act Act Act CD38 T10, gp45, ADP-ribosyl cyclase Act p n p p p p l CD144 VE-cadherin, cadherin-5 n n n n n n n n p n l CD277 BT3.1, BTF5 p p p p p p CD39 gp80, E-ATPDase, NTPDase-1 S / Act Act p p n p p p l CDw145 - n n n n n p p CD278 ICOS (inducible costimulator) Act l CD40 Bp50, TNF receptor 5 S p n n p n S Folli p S l CD146 MUC18, S-Endo, MCAM, Mel-CAM, A32 S / Act n n n n n n Folli p l CD279 PD1, PDC1 Act Act Act l CD41 platelet GPIIb, aIIb integrin, HPA3 n n n n n p n p n n n l CD147 EMMPRIN (extracellular metalloprotein inducer), M6, basigin p p p p p p p p CD280 Endo180, TEM22, MRC2 p p p CD42a platelet GPIX, gp9 n n n n n p n p n n n l CD148 HPTP-h, DEP-1, p260 p p p p p p p n CD281 TLR1 (TOLL-like receptor 1), TIL p p CD42b platelet GPIb-a, Glycocalicin n n n n n p n p n n n l CD149 Now CD47R Now CD47R CD282 TLR2 (TOLL-like receptor 2), TIL4 p p CD42c platelet GPIb-b n n n n n p n p n n n CD150 SLAM (signaling lymphocyte activation molecule), IPO-3 S S n n n n n p p CD283 TLR3 (TOLL-like receptor 3) p p n n n p CD42d platelet GPV n n n n n p n p n n n CD151 PETA-3 (platelet-endothelial tetra-span antigen), SFA-1, Tspan-24 n n n n p p n p p CD284 TLR4 (TOLL-like receptor 4) p CD43 leukosialin, sialophorin, gpL115, gp95 p Act p p S Low n p l CD152 CTLA-4 (cytotoxic T lymphocyte antigen) S / Act S / Act n n n n n l CD285 TLR5 (TOLL-like receptor 5), TIL3 p S CD44 Pgp-1; gp80-95, Hermes antigen, ECMR-III, HUTCH-I, H-CAM p p p p p n p p p l CD153 CD30 ligand, CD30L Act p Act n CD286 TLR6 (TOLL-like receptor 6) p p p CD44R CD44v1-10, CD44 variant Act Act Act p p CD154 CD40 ligand, CD40L, gp39, TRAP, T-BAM Act Act p Act n p n l CD287 TLR7 (TOLL-like receptor 7) p S CD45 LCA, T200, B220, EC 3.1.3.4 p p p p p n n p p n n l CD155 PVR (polio virus receptor), nectin-like 5 p n n CD288 TLR8 (TOLL-like receptor 8) p p p CD45RA
Load more

Recommended publications
  • 4-1BB Signaling Beyond T Cells
    Cellular & Molecular Immunology (2011) 8, 281–284 ß 2011 CSI and USTC. All rights reserved 1672-7681/11 $32.00 www.nature.com/cmi MINI REVIEW 4-1BB signaling beyond T cells Dass S Vinay1 and Byoung S Kwon1,2 Originally discovered as a T cell-activating molecule, 4-1BB (CD137) is now also recognized as an activator of non-T cells, thus imparting a new dimension to its potential in vivo effects. 4-1BB expression is seen on a variety of non-T cells including activated dendritic cells (DCs), monocytes, neutrophils, B cells and natural killer (NK) cells, and promotes their individual effector functions. The T cell- and non-T cell-activating ability of 4-1BB may be the basis of its powerful anti-cancer, anti-autoimmune and anti-viral effects. Here we discuss the consequence and importance of 4-1BB signaling in non-T cells. We consider its effects on immune regulation, and the distinct and/or overlapping pathways involved in these responses, as well as possible therapeutic applications. Cellular & Molecular Immunology (2011) 8, 281–284; doi:10.1038/cmi.2010.82; published online 10 January 2011 Keywords: APC; cytokines; natural killer cells; T cells; 4-1BB INTRODUCTION focus on the functions of 4-1BB in non-T cells including DCs, mono- 4-1BB (CD137; TNFRSF9), discovered originally on T cells,1 is a 50- cytes, neutrophils, B cells and NK cells, and discuss how its expression to 55-kDa protein concerned with progressive immunity.2,3 4-1BB might be manipulated to treat various immune diseases. expression is in most cases activation induced.
    [Show full text]
  • ENSG Gene Encodes Effector TCR Pathway Costimulation Inhibitory/Exhaustion Synapse/Adhesion Chemokines/Receptors
    ENSG Gene Encodes Effector TCR pathway Costimulation Inhibitory/exhaustion Synapse/adhesion Chemokines/receptors ENSG00000111537 IFNG IFNg x ENSG00000109471 IL2 IL-2 x ENSG00000232810 TNF TNFa x ENSG00000271503 CCL5 CCL5 x x ENSG00000139187 KLRG1 Klrg1 x ENSG00000117560 FASLG Fas ligand x ENSG00000121858 TNFSF10 TRAIL x ENSG00000134545 KLRC1 Klrc1 / NKG2A x ENSG00000213809 KLRK1 Klrk1 / NKG2D x ENSG00000188389 PDCD1 PD-1 x x ENSG00000117281 CD160 CD160 x x ENSG00000134460 IL2RA IL-2 receptor x subunit alpha ENSG00000110324 IL10RA IL-10 receptor x subunit alpha ENSG00000115604 IL18R1 IL-18 receptor 1 x ENSG00000115607 IL18RAP IL-18 receptor x accessory protein ENSG00000081985 IL12RB2 IL-12 receptor x beta 2 ENSG00000186810 CXCR3 CXCR3 x x ENSG00000005844 ITGAL CD11a x ENSG00000160255 ITGB2 CD18; Integrin x x beta-2 ENSG00000156886 ITGAD CD11d x ENSG00000140678 ITGAX; CD11c x x Integrin alpha-X ENSG00000115232 ITGA4 CD49d; Integrin x x alpha-4 ENSG00000169896 ITGAM CD11b; Integrin x x alpha-M ENSG00000138378 STAT4 Stat4 x ENSG00000115415 STAT1 Stat1 x ENSG00000170581 STAT2 Stat2 x ENSG00000126561 STAT5a Stat5a x ENSG00000162434 JAK1 Jak1 x ENSG00000100453 GZMB Granzyme B x ENSG00000145649 GZMA Granzyme A x ENSG00000180644 PRF1 Perforin 1 x ENSG00000115523 GNLY Granulysin x ENSG00000100450 GZMH Granzyme H x ENSG00000113088 GZMK Granzyme K x ENSG00000057657 PRDM1 Blimp-1 x ENSG00000073861 TBX21 T-bet x ENSG00000115738 ID2 ID2 x ENSG00000176083 ZNF683 Hobit x ENSG00000137265 IRF4 Interferon x regulatory factor 4 ENSG00000140968 IRF8 Interferon
    [Show full text]
  • (CD147) Is Induced by C/Ebpβ and Is Differentially Expressed in ALK+
    Laboratory Investigation (2017) 97, 1095–1102 © 2017 USCAP, Inc All rights reserved 0023-6837/17 EMMPRIN (CD147) is induced by C/EBPβ and is differentially expressed in ALK+ and ALK − anaplastic large-cell lymphoma Janine Schmidt1, Irina Bonzheim1, Julia Steinhilber1, Ivonne A Montes-Mojarro1, Carlos Ortiz-Hidalgo2, Wolfram Klapper3, Falko Fend1 and Leticia Quintanilla-Martínez1 Anaplastic lymphoma kinase-positive (ALK+) anaplastic large-cell lymphoma (ALCL) is characterized by expression of oncogenic ALK fusion proteins due to the translocation t(2;5)(p23;q35) or variants. Although genotypically a T-cell lymphoma, ALK+ ALCL cells frequently show loss of T-cell-specific surface antigens and expression of monocytic markers. C/EBPβ, a transcription factor constitutively overexpressed in ALK+ ALCL cells, has been shown to play an important role in the activation and differentiation of macrophages and is furthermore capable of transdifferentiating B-cell and T-cell progenitors to macrophages in vitro. To analyze the role of C/EBPβ for the unusual phenotype of ALK+ ALCL cells, C/EBPβ was knocked down by RNA interference in two ALK+ ALCL cell lines, and surface antigen expression profiles of these cell lines were generated using a Human Cell Surface Marker Screening Panel (BD Biosciences). Interesting candidate antigens were further analyzed by immunohistochemistry in primary ALCL ALK+ and ALK − cases. Antigen expression profiling revealed marked changes in the expression of the activation markers CD25, CD30, CD98, CD147, and CD227 after C/EBPβ knockdown. Immunohistochemical analysis confirmed a strong, membranous CD147 (EMMPRIN) expression in ALK+ ALCL cases. In contrast, ALK − ALCL cases showed a weaker CD147 expression.
    [Show full text]
  • Cd160 Mouse Shrna Plasmid (Locus ID 54215) – TR514223 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TR514223 Cd160 Mouse shRNA Plasmid (Locus ID 54215) Product data: Product Type: shRNA Plasmids Product Name: Cd160 Mouse shRNA Plasmid (Locus ID 54215) Locus ID: 54215 Synonyms: AU045688; By55 Vector: pRS (TR20003) Format: Retroviral plasmids Components: Cd160 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 54215). 5µg purified plasmid DNA per construct Non-effective 29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. RefSeq: BC021596, NM_001163496, NM_001163497, NM_018767 Summary: CD160 antigen: Receptor on immune cells capable to deliver stimulatory or inhibitory signals that regulate cell activation and differentiation. Exists as a GPI-anchored and as a transmembrane form, each likely initiating distinct signaling pathways via phosphoinositol 3- kinase in activated NK cells and via LCK and CD247/CD3 zeta chain in activated T cells (By similarity). Receptor for both classical and non-classical MHC class I molecules (PubMed:16177084). Receptor or ligand for TNF superfamily member TNFRSF14, participating in bidirectional cell-cell contact signaling between antigen presenting cells and lymphocytes. Upon ligation of TNFRSF14, provides stimulatory signal to NK cells enhancing IFNG production and anti-tumor immune response (PubMed:25711213). On activated CD4+ T cells, interacts with TNFRSF14 and downregulates CD28 costimulatory signaling, restricting memory and alloantigen-specific immune response (By similarity). In the context of bacterial infection, acts as a ligand for TNFRSF14 on epithelial cells, triggering the production of antimicrobial proteins and proinflammatory cytokines (PubMed:22801499).[UniProtKB/Swiss-Prot Function] shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus.
    [Show full text]
  • Fine Tuning by Human Cd1e of Lipid-Specific Immune Responses
    Fine tuning by human CD1e of lipid-specific immune responses Federica Facciottia, Marco Cavallaria, Catherine Angénieuxb, Luis F. Garcia-Allesc, François Signorino-Gelob, Lena Angmana, Martine Gilleronc, Jacques Prandic, Germain Puzoc, Luigi Panzad, Chengfeng Xiae, Peng George Wangf, Paolo Dellabonag, Giulia Casoratig, Steven A. Porcellih, Henri de la Salleb, Lucia Moria,i,1, and Gennaro De Liberoa,1 aExperimental Immunology, Department of Biomedicine, University Hospital Basel, 4031 Basel, Switzerland; bInstitut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S725, Biology of Human Dendritic Cells, Université de Strasbourg and Etablissement Français du Sang-Alsace, 67065 Strasbourg, France; cCentre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale, 31077 Toulouse, France; dDepartment of Chemistry, Food, Pharmaceuticals, and Pharmacology, Università del Piemonte Orientale, 28100 Novara, Italy; eState Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, Yunnan 650204, China; fDepartment of Biochemistry and Chemistry, The Ohio State University, Columbus, OH 43210; gExperimental Immunology Unit, Division of Immunology, Transplantation, and Infectious Diseases, Dipartimento di Biotecnologie (DIBIT), San Raffaele Scientific Institute, 20132 Milano, Italy; hAlbert Einstein College of Medicine, Bronx, NY 10461; and iSingapore Immunology Network, Agency for Science Technology and Research, Biopolis, Singapore 138648 Edited by Peter Cresswell, Yale University School of Medicine, New Haven, CT, and approved July 20, 2011 (received for review June 5, 2011) CD1e is a member of the CD1 family that participates in lipid an- molecules traffic to early recycling endosomes and, to a lesser tigen presentation without interacting with the T-cell receptor.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Viewed Under 23 (B) Or 203 (C) fi M M Male Cko Mice, and Largely Unaffected Magni Cation; Scale Bars, 500 M (B) and 50 M (C)
    BRIEF COMMUNICATION www.jasn.org Renal Fanconi Syndrome and Hypophosphatemic Rickets in the Absence of Xenotropic and Polytropic Retroviral Receptor in the Nephron Camille Ansermet,* Matthias B. Moor,* Gabriel Centeno,* Muriel Auberson,* † † ‡ Dorothy Zhang Hu, Roland Baron, Svetlana Nikolaeva,* Barbara Haenzi,* | Natalya Katanaeva,* Ivan Gautschi,* Vladimir Katanaev,*§ Samuel Rotman, Robert Koesters,¶ †† Laurent Schild,* Sylvain Pradervand,** Olivier Bonny,* and Dmitri Firsov* BRIEF COMMUNICATION *Department of Pharmacology and Toxicology and **Genomic Technologies Facility, University of Lausanne, Lausanne, Switzerland; †Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts; ‡Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia; §School of Biomedicine, Far Eastern Federal University, Vladivostok, Russia; |Services of Pathology and ††Nephrology, Department of Medicine, University Hospital of Lausanne, Lausanne, Switzerland; and ¶Université Pierre et Marie Curie, Paris, France ABSTRACT Tight control of extracellular and intracellular inorganic phosphate (Pi) levels is crit- leaves.4 Most recently, Legati et al. have ical to most biochemical and physiologic processes. Urinary Pi is freely filtered at the shown an association between genetic kidney glomerulus and is reabsorbed in the renal tubule by the action of the apical polymorphisms in Xpr1 and primary fa- sodium-dependent phosphate transporters, NaPi-IIa/NaPi-IIc/Pit2. However, the milial brain calcification disorder.5 How- molecular identity of the protein(s) participating in the basolateral Pi efflux remains ever, the role of XPR1 in the maintenance unknown. Evidence has suggested that xenotropic and polytropic retroviral recep- of Pi homeostasis remains unknown. Here, tor 1 (XPR1) might be involved in this process. Here, we show that conditional in- we addressed this issue in mice deficient for activation of Xpr1 in the renal tubule in mice resulted in impaired renal Pi Xpr1 in the nephron.
    [Show full text]
  • Tools for Cell Therapy and Immunoregulation
    RnDSy-lu-2945 Tools for Cell Therapy and Immunoregulation Target Cell TIM-4 SLAM/CD150 BTNL8 PD-L2/B7-DC B7-H1/PD-L1 (Human) Unknown PD-1 B7-1/CD80 TIM-1 SLAM/CD150 Receptor TIM Family SLAM Family Butyrophilins B7/CD28 Families T Cell Multiple Co-Signaling Molecules Co-stimulatory Co-inhibitory Ig Superfamily Regulate T Cell Activation Target Cell T Cell Target Cell T Cell B7-1/CD80 B7-H1/PD-L1 T cell activation requires two signals: 1) recognition of the antigenic peptide/ B7-1/CD80 B7-2/CD86 CTLA-4 major histocompatibility complex (MHC) by the T cell receptor (TCR) and 2) CD28 antigen-independent co-stimulation induced by interactions between B7-2/CD86 B7-H1/PD-L1 B7-1/CD80 co-signaling molecules expressed on target cells, such as antigen-presenting PD-L2/B7-DC PD-1 ICOS cells (APCs), and their T cell-expressed receptors. Engagement of the TCR in B7-H2/ICOS L 2Ig B7-H3 (Mouse) the absence of this second co-stimulatory signal typically results in T cell B7-H1/PD-L1 B7/CD28 Families 4Ig B7-H3 (Human) anergy or apoptosis. In addition, T cell activation can be negatively regulated Unknown Receptors by co-inhibitory molecules present on APCs. Therefore, integration of the 2Ig B7-H3 Unknown B7-H4 (Mouse) Receptors signals transduced by co-stimulatory and co-inhibitory molecules following TCR B7-H5 4Ig B7-H3 engagement directs the outcome and magnitude of a T cell response Unknown Ligand (Human) B7-H5 including the enhancement or suppression of T cell proliferation, B7-H7 Unknown Receptor differentiation, and/or cytokine secretion.
    [Show full text]
  • Megakaryopoiesis in Dengue Virus Infected K562 Cell Promotes Viral Replication Which Inhibits 2 Endomitosis and Accumulation of ROS Associated with Differentiation
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.25.172544; this version posted June 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Title: Megakaryopoiesis in Dengue virus infected K562 cell promotes viral replication which inhibits 2 endomitosis and accumulation of ROS associated with differentiation 3 Jaskaran Kaur *1, Yogita Rawat *1, Vikas Sood 2, Deepak Rathore1, Shrikant K. Kumar1, Niraj K. Kumar1 4 and Sankar Bhattacharyya1 5 1 Translational Health Science and Technology Institute, NCR Biotech Science Cluster, PO Box# 4, 6 Faridabad-Gurgaon expressway, Faridabad, Haryana-121001, India 7 2 Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard (Hamdard 8 University) Hamdard Nagar, New Delhi - 110062, India 9 10 *Equal contribution 11 Email for correspondence: [email protected] 12 13 14 Keywords: Dengue virus replication, Megakaryopoiesis, Reactive oxygen species, Endomitosis 15 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.25.172544; this version posted June 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 16 Abstract: In the human host blood Monocytes and bone marrow Megakaryocytes are implicated as major 17 sites supporting high replication. The human K562 cell line supports DENV replication and represent 18 Megakaryocyte-Erythrocyte progenitors (MEP), replicating features of in vivo Megakaryopoiesis upon 19 stimulation with Phorbol esters. In this article, we report results that indicate the mutual influence of 20 Megakaryopoiesis and DENV replication on each other, through comparison of PMA-induced 21 differentiation of either mock-infected or DENV-infected K562 cells.
    [Show full text]
  • CD200, Human Recombinant Recombinant Human CD200, : 408-493-1800 | Fax: 408-493-1801 408-493-1801 Fax: | 408-493-1800
    BioVision 1/14 For research use only CD200, human recombinant CATALOG #: 7309-50 50 µg ALTERNATE NAMES: CD200 molecule, MOX1, MOX2, MRC, OX-2 SOURCE: E. coli PURITY: > 90% by SDS-PAGE MOL. WEIGHT: 24.8 kDa (225 aa, 31-232 aa + His tag), confirmed by MALDI-TOF. ENDOTOXIN LEVEL: < 1.0 EU per 1 µg of protein FORM: Liquid FORMULATION: 1 mg/ml in 20 mM Tris-HCl buffer (pH 8.0) containing 0.4M Urea. CD200, human recombinant STORAGE CONDITIONS: Can be stored at 4°C short term (1-2 weeks). For long term storage, aliquot and store at -20°C or - 70°C. Avoid repeated freezing and thawing RELATED PRODUCTS: cycles. • CD1E, human recombinant (Cat. No. 7308-100) • CD226, human recombinant (Cat. No. 7310-100) DESCRIPTION : CD200 is a type-1 membrane glycoprotein, which contains two • CD274, mouse recombinant (Cat. No. 7311-100) immunoglobulin domains, and thus belongs to the immunoglobulin superfamily. Studies of • CD300C, human recombinant (Cat. No. 7312-100) the related genes in mouse and rat suggest that this gene may regulate myeloid cell • CD3G, human recombinant (Cat. No. 7313-100) activity and delivers an inhibitory signal for the macrophage lineage in diverse tissues. • CD46, human recombinant (Cat. No. 7314-100) Multiple alternatively spliced transcript variants that encode different isoforms have been • CD5, human recombinant (Cat. No. 7315-100) • CD7, human recombinant (Cat. No. 7316-100) found for this gene. Recombinant human CD200 protein, fused to His-tag at N-terminus, • CD74, human recombinant (Cat. No. 7317-100) was expressed in E.coli. • CD79B, human recombinant (Cat.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation
    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
    [Show full text]